ITGB1 and primary cutaneous T-cell non-Hodgkin lymphoma: Notably, ITGB1 upregulation and signaling were detected in patients with leukemic CTCL (66) and were associated with tumor cell trafficking, survival, proliferation, and resistance to apoptosis (66).